144 related articles for article (PubMed ID: 7831773)
1. Characterization of the Epstein-Barr virus Fp promoter.
Nonkwelo C; Henson EB; Sample J
Virology; 1995 Jan; 206(1):183-95. PubMed ID: 7831773
[TBL] [Abstract][Full Text] [Related]
2. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
Nonkwelo C; Skinner J; Bell A; Rickinson A; Sample J
J Virol; 1996 Jan; 70(1):623-7. PubMed ID: 8523583
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.
Sung NS; Wilson J; Davenport M; Sista ND; Pagano JS
Mol Cell Biol; 1994 Nov; 14(11):7144-52. PubMed ID: 7935429
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines.
Schaefer BC; Strominger JL; Speck SH
J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074
[TBL] [Abstract][Full Text] [Related]
5. Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus.
Bulfone-Paus S; Dempsey LA; Maizels N
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8293-7. PubMed ID: 7667284
[TBL] [Abstract][Full Text] [Related]
6. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.
Sample J; Henson EB; Sample C
J Virol; 1992 Aug; 66(8):4654-61. PubMed ID: 1321268
[TBL] [Abstract][Full Text] [Related]
7. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
8. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene.
Tsai CN; Liu ST; Chang YS
DNA Cell Biol; 1995 Sep; 14(9):767-76. PubMed ID: 7669254
[TBL] [Abstract][Full Text] [Related]
10. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Puglielli MT; Woisetschlaeger M; Speck SH
J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191
[TBL] [Abstract][Full Text] [Related]
11. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.
Nonkwelo C; Ruf IK; Sample J
J Virol; 1997 Sep; 71(9):6887-97. PubMed ID: 9261415
[TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.
Nonkwelo C; Ruf IK; Sample J
J Virol; 1997 Jan; 71(1):354-61. PubMed ID: 8985357
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E
J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
[TBL] [Abstract][Full Text] [Related]
14. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
15. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
[TBL] [Abstract][Full Text] [Related]
16. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
Sample J; Brooks L; Sample C; Young L; Rowe M; Gregory C; Rickinson A; Kieff E
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6343-7. PubMed ID: 1648738
[TBL] [Abstract][Full Text] [Related]
17. The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site.
Zetterberg H; Jansson A; Rymo L; Chen F; Karlsson A; Klein G; Brodin B
J Gen Virol; 2002 Aug; 83(Pt 8):2007-2014. PubMed ID: 12124465
[TBL] [Abstract][Full Text] [Related]
18. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
Schaefer BC; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10565-9. PubMed ID: 7479841
[TBL] [Abstract][Full Text] [Related]
19. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
Zhao B; Sample CE
J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
[TBL] [Abstract][Full Text] [Related]
20. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
